Marian Bendik obtained his master’s degree in Biochemistry from the University of Chemistry and Technology, Prague in 2006. He then worked as an immunoassay research scientist in academia and later in industry. Afterwards, he occupied different process and manufacturing expert roles with increased responsibilities in the cell-based vaccines business unit for six years at Baxter Bioscience. In 2014 he joined the gene therapy process development team to provide a commercial-scale process perspective to speed up the scale-up and commercialization of the AAV manufacturing platform. Currently, he holds overall accountability for upstream and downstream process development for gene therapy products.